Visceral adiposity and the prevalence of glucose intolerance: A predictive cut-off value.

Faculty Medicine Year: 2016
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Journal of The Egyptian Society of Nephrology and Transplantation International Journal of Advanced Research Volume:
Keywords : Visceral adiposity , , prevalence , glucose intolerance: , predictive    
Abstract:
Background: The Visceral Adiposity Index (VAI) is a sex-specific mathematical index indirectly expressing visceral adipose function and insulin sensitivity. Our aim was to find the optimal cut-off points of VAI identifying a visceral adipose dysfunction (VAD) associated with glucose intolerance. Materials and Methods: This was a cross-sectional research that carried out on the 508 subjects (212 males and 296 females) using random collection sampling technique. FBG was measured in the morning after a 12-hour fast and the examination included also a 75-g oral glucose tolerance test and anthropometric measurements. Receiver operating characteristic curve and area under curve were applied to compare the ability of identifying impaired glucose tolerance (IGT) and diabetes risk and VAI. Results: As whole, the mean of VAI in subjects with abnormal glucose (2.5 ± 0.94 mg/dl) was higher than in subjects with normal glucose tolerance tests (1.65 ± 0.56 mg/dl). Also, the mean of VAI in DM was higher than in IGT (2.94 + 0.94 versus 2.79 + 0.96). There were positively correlation between VAI and fasting and postprandial glucose (P=<0.001 for both). The cut-off points of VAI for screening and diagnosis of glucose intolerance are 1.7677 and 2.5579, respectively. Conclusion: Greater visceral adiposity increases the risk of IGT and DM. Also, our study suggests that among our subjects there is clear cut-off points of VAI able to identify a VAD strongly associated with glucose intolerance. VAI is useable as a predictor of glucose intolerance and type 2 DM risk among adults.
   
     
 
       

Author Related Publications

  • Walid Abdel-Fattah Mohamed Ismail, "Evaluation of liver fat content with magnetic resonance spectroscopy in overweight subjects as an early detector o fatty liver disease and correlation with liver biopsy", JHGR, 2014 More
  • Walid Abdel-Fattah Mohamed Ismail, "THE YEILD OF MAPPING BIOPSY IN ENDOSCOPICALLY NORMALOLON AND ITSCORRELATION WITH BIOPSY", JHGR, 2014 More
  • Walid Abdel-Fattah Mohamed Ismail, "DOES VISCERAL ADIPOSITY INFLUENCE THE STANDARD OF CARE FOR HEPATITIS C PATIENTS", JASR, 2014 More
  • Walid Abdel-Fattah Mohamed Ismail, "Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents", Le Infezioni in Medicina, 2018 More
  • Walid Abdel-Fattah Mohamed Ismail, "Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection", WHO Fact sheet No. 164, June 2011, 2011 More

Department Related Publications

  • Ayman Abdalrahman Mohamed Nasrllah, "Thyroid Dysfunction and Inflammatory Biomarkers in COPD:Relation to Severity and Exacerbation", Cairo,Egypt, 2013 More
  • Emad Fawzy Hamed Mahmoud, "ANNEXIN A2 VERSUS AFP AS AN EFFICIENT DIAGNOSTIC SERUM MARKER FOR HEPATOCELLULAR CARCINOMA", المجله المصريه الافريقيه للامراض المتوطنه, 2013 More
  • Emad Fawzy Hamed Mahmoud, "PARAOXONASE 1 Gene Polymorphism Relationship with Type 2 Diabetes Mellitus", life science journal, 2012 More
  • Ayman Abdalrahman Mohamed Nasrllah, "Microalbuminurea Screening and Risk factors in adolescents with type 1 Diabetes Mellitus In Zagazig University Hospital n", London, 2012 More
  • Ayman Abdalrahman Mohamed Nasrllah, "Predicting Insulin Resistance Using Triglyceride to High Density Lipoprotein Ratio In Egyptian Adults", Zagazig University,Medical College, 2013 More
Tweet